Protective protein/cathepsin A (PPCA) is a pleiotropic lysosomal enzyme that complexes with β-galactosidase and neuraminidase, and possesses serine carboxypeptidase activity. Its deficiency in man results in the neurodegenerative lysosomal storage disorder galactosialidosis (GS). The mouse model of this disease resembles the human early onset phenotype and results in severe nephropathy and ataxia. To understand better the pathophysiology of the disease, we compared the occurrence of lysosomal PPCA mRNA and protein in normal adult mouse tissues with the incidence of lysosomal storage in PPCA(-/-) mice. PPCA expression was markedly variable among different tissues. Most sites that produced both mRNA and protein at high levels in normal mice showed extensive and overt storage in the knockout mice. However, this correlation was not consistent as some cells that normally expressed high levels of PPCA were unaffected in their storage capability in the PPCA(-/-) mice. In addition, some normally low expressing cells accumulated large amounts of undegraded products in the GS mouse. This apparent discrepancy may reflect a requirement for the catalytic rather than the protective function of PPCA and/or the presence of cellspecific substrates in certain cell types. A detailed map showing the cellular distribution of PPCA in nomal mouse tissues as well as the sites of lysosomal storage in deficient mice is critical for accurate assessment of the effects of therapeutic interventions.
INTRODUCTION
Lysosomal protective protein/cathepsin A (PPCA) is a serine carboxypeptidase that forms a high molecular weight multienzyme complex with acid β-D-galactosidase and N-acetyl-α-neuraminidase (1-6). PPCA's role in this complex is to facilitate the intracellular routing, lysosomal localization and activation of neuraminidase (7, 8) , and to stabilize β-galactosidase in the lysosomal environment (5, 9) . Genetic lesions in the PPCA gene that abolish its protective function cause severe loss of neuraminidase activity, and render β-galactosidase susceptible to rapid intralysosomal proteolysis (10, 11) . The resulting combined enzyme deficiency is the basis of the lysosomal storage disorder galactosialidosis (GS), which is characterized by the primary accumulation of sialylated oligosaccharides and glycopeptides in patient tissues and body fluids (12) (13) (14) (15) . Patients with GS present clinically with one of three forms of the disease (early infantile, late infantile or juvenile/adult), depending on their age at onset and the severity of their symptoms (16) . The early onset patients, who completely lack PPCA activity, die within the first months of life from heart and kidney failure. The mouse model of GS closely resembles the phenotype of early infantile patients (17) . Extensive vacuolation of certain cells in most organs is caused by the abnormal accumulation of undigested metabolites that result primarily from the severe secondary deficiency of lysosomal neuraminidase. As a member of the serine protease family, PPCA exerts cathepsin A activity at acidic pH and esterase/C-terminal deamidase activity at neutral pH. The catalytic activity of PPCA, which is fully separable from its protective function (18) , is apparently important for the initial catalysis of selected bioactive peptides, including substance P, oxytocin and endothelin I (19) (20) (21) (22) . However, the physiological significance of this enzyme activity has not yet been proven. Recently, we identified the minimal promoter regions of the human and mouse PPCA genes (23) . Transcription of the murine gene, unlike that of the human gene, gives rise to two differentially expressed transcripts that contain the same protein-encoding region. The more abundant 1.8 kb species is expressed in all tissues and originates from a promoter with features characteristic of housekeeping gene promoters (23) . A minor murine-specific 2.0 kb mRNA is transcribed from a TATA box-containing promoter and is expressed at lower levels in specific tissues.
Here, we studied the in vivo expression of PPCA in adult murine tissues by using in situ hybridization and immunocytochemistry. Our aim was to correlate the distribution pattern of PPCA mRNA and protein in normal mice with the disease pathology in the knockout mouse. Our findings demonstrate that PPCA expression is not ubiquitous in normal adult tissues, but rather is confined preferentially to specific cells, especially those that are metabolically active. Most regions that express PPCA at high levels develop overt morphologic changes in the knockout mouse. Interestingly, however, there are also cell types where the correlation between gene expression and the occurrence of lysosomal storage is not maintained. We discuss how this result could suggest a role for the catalytic rather than the protective function of PPCA.
RESULTS
The distribution of PPCA mRNA and protein in the tissues of normal adult mice was analyzed using in situ hybridization and immunocytochemistry, respectively. The presence of lysosomal storage material in defined cell populations of GS mice was evidenced by periodic acid Schiff (PAS) staining and lysosomal vacuolation.
Brain
Despite a generalized expression of PPCA in the brain, regional and cellular differences were obvious. The frontal, parietal and occipital lobes of the cortex displayed a moderate signal throughout the inner five layers, whereas the external layer, which contains unmyelinated axons, was devoid of PPCA-specific signal (Fig. 1A) . The inferior colliculus and cells within the meningeal layers also contained PPCA transcripts and protein.
The expression in the cortex and the diencephalon was confined primarily to neuronal cell bodies rather than to nerve fibers. Sustained expression of PPCA mRNA was detected throughout the olfactory bulb, being most prominent at the level of the mitral cell layer (Fig. 1B) . This was paralleled by strong punctated PPCA staining in the large mitral cells (Fig. 1C) . Weak expression was present in the granular cells and the periglomerular neurons. The axons of the mitral cells are in contact with the olfactory cortex, which consists of five defined regions: the anterior olfactory nuclei, the tuberculum olfactorium, the pyriform cortical neurons, the amygdala and the entorhinal cortex. All of these areas, which belong to the limbic system, and in particular the tuberculum olfactorium and the pyriform nuclear cells, expressed PPCA mRNA and protein at high levels (not shown). The pyramidal neurons of the hippocampus and the granular cells of the dentate gyrus were also highly positive for both mRNA and protein ( Fig. 1E and F) . Only basal expression levels were detected in the caudate putamen, the thalamic and hypothalamic regions, and the substantia nigra (not shown). In the cerebellum, a strong positive signal was confined to the Purkinje cells, whereas the molecular and granular layers had significantly lower expression ( Fig. 1H and I) . The large neurons of the cerebellar nucleus also stained strongly. Like the cerebrum and the cerebellum, the brain stem expressed PPCA primarily in gray matter nuclei, containing the cell bodies of the different neurons. Both PPCA transcripts and protein were very prominent in the epithelial cells of the choroid plexus, whereas expression in the ependymal cells that line the cerebral ventricles was low (Fig. 1K and L). Strong expression was detected in the perivascular and leptomeningeal macrophages.
In general, PPCA expression in the brain correlated well with the distribution of vacuolated cells with lysosomal storage in the PPCA(-/-) mouse. PAS-positive cells appeared early in life. At 2 months of age, they were detected only in the anterior olfactory nucleus, the amygdala and the entorhinal cortex (not shown). Occasional Purkinje cells were also positive. As the disease progressed, the number of accumulating cells became more conspicuous in these regions; other neurons also appeared positive, including mitral cells (Fig. 1D) , neurons of the 3rd-4th cerebral cortical layer, scattered cells of the thalamus and hypothalamus, and the large neurons of the cerebellar nucleus and brain stem (not shown). Interestingly, PAS-positive staining differed in different vacuolated cell types, probably reflecting variation in the composition of storage products. The choroid plexus, for example, showed clear morphological changes without evident PAS staining (Fig. 1M) . Contrary to what might be expected from the high PPCA expression in the pyramidal neurons of the hippocampus and the granular cells of the dentate gyrus, very few PAS-positive or vacuolated cells were detected in these areas (Fig. 1G ). This apparent inconsistency could be attributed to differences in the metabolic state of these cells or to the type of macromolecular substrates. Furthermore, there appeared to be a variable effect of the storage products on cell viability. Purkinje cells display few large PAS-positive granules prior to cell death ( Fig. 1J ), whereas cerebellar basket cells, and cells of the amygdala and anterior olfactory nucleus, become filled with PAS-positive material prior to obvious signs of cellular deterioration (not shown). It should also be noted that the undegraded products accumulate first in the Purkinje cells of the more anterior lobules which also die earliest. As the disease progresses, however, Purkinje cells in more posterior regions store and die. Loss of these cells contributes to the progressive ataxia seen in these mice (17) . Interestingly, a similar feature was observed in other mouse models of lysosomal storage disorders such as Niemann-Pick A and C (24) (25) (26) (27) .
Visceral organs
PPCA mRNA expression was distributed throughout the liver ( Fig. 2A) . Immunocytochemistry clearly demonstrated that the protein expression was moderate in hepatocytes and high in Kupffer cells (Fig. 2B ), reflecting the storage pattern detected in , the hippocampus and dentate gyrus (E-G), the Purkinje cell layer of the cerebellum (H-J) and the choroid plexus (K-M). Note the PAS-positive storage granules in the mitral (D) and Purkinje cells (J), the lack of storage in the hippocampus and dentate gyrus (G), and the PAS-negative storage vacuoles in the choroid plexus (M). Mice of age 2-6 months were used for in situ RNA hybridization and immunocytochemistry, and mice of 10-13 months were used for PAS staining although storage was visible in some cells earlier. All in situ RNA hybridization and PAS staining were performed on frozen sections, and immunocytochemistry was performed on paraffin sections. Scale bar = 1 mm (A), 250 µm (E, G and H), 50 µm (B-D, F and I-M). the knockout mouse, where Kupffer cells are more affected than hepatocytes (Fig. 2C) . The red pulp of the spleen showed higher protein and mRNA expression than the white pulp, probably because of the numerous macrophages that express high levels of PPCA ( Fig. 2D and E) . Consistent with this, the pathology of the spleen in the (-/-) mouse showed macrophages filled with vacuoles, whereas lymphocytes and megakaryocytes displayed little or no signs of storage. As a result of accumulating products in the liver and spleen, the affected mice develop hepatosplenomegaly, a clinical feature associated with the early and sometimes late infantile forms of the human disease (16) .
In the kidney of wild-type mice, PPCA expression was high in the cuboidal epithelium of the proximal convoluted tubules and somewhat lower in the distal convoluted tubules of the nephron ( Fig. 2G and H) . The epithelial cells of Bowman's capsule were highly positive, whereas the glomerulus expressed very low levels that could be seen only weakly by immunocytochemistry (Fig. 2H) . No expression was detected in the renal medulla. The epithelia of the proximal convoluted tubules and the Bowman's capsule were the first sites to store overtly in PPCA(-/-) mice (Fig. 2I) . Interestingly, although the expression was very low in the glomerulus of the wild-type mouse, this region of the deficient mouse displayed high levels of storage (17) . This severe renal pathology in knockout mice resulted in diffuse edema and closely paralleled the nephrotic syndrome seen in GS patients (16) .
In the duodenum and jejunum of the small intestine, the crypts of Lieberkuhn expressed high levels of PPCA mRNA, but little protein, whereas the mucosal layer of the microvilli expressed moderately (Fig. 2J and K) . In (-/-) mice, storage products or vacuolation were not detected in these cells (Fig. 2L) . However, foamy macrophages were seen in the interstitial space of the mucosa, submucosa, muscular outer layer and the lymphoid Peyer's patches (not shown).
Heart and skeletal muscle appeared to have an overall, low PPCA expression. In muscle fibers, the knockout mouse displayed vacuolation only within endothelial cells and macrophages, but showed no signs of storage. The adrenal gland showed high expression in a specific rim of cells, probably the X zone, which is loosely defined between the cortical and the medullar cell layers (not shown). Cells in this layer secrete glucocorticoids and androgens, and are only present in sexually immature male and virgin female mice (28) . PPCA(-/-) mice did not show detectable levels of storage products in the adrenal gland.
Reproductive system: testis and epididymis
Within the seminiferous tubules of the testis, PPCA expression was observed in the Sertoli cells, which provide nutrients to the developing spermatocytes. No expression was noted in the spermatogonia or spermatocytes (Fig. 3A and B) . Moderate mRNA and protein levels were also detected in the interstitial cells of Leydig, which surround the seminiferous tubules and secrete testosterone under the influence of luteinizing hormone. Interestingly, the PPCA signal varied along the length of the epididymis. Most proximal to the testis, in the caput epididymis, PPCA levels were very high in the columnar epithelial cells of the ducts with little or no apparent expression in the supportive connective tissue (Fig. 3D and E) . Further along through the corpus of the epididymis, the number of expressing cells decreased to the cauda, where only a few expressed high levels of the protein (data not shown).
In the (-/-) mice, extensive vacuolation occurred in all high expressing cells and, in addition, in the interstitial cells ( Fig. 3C  and F) . Marked vacuolation of the epididymis and Leydig cells was already visible at 2 months of age, and these cells remained viable, but markedly affected, for the life of the animals.
Ovary and uterus
The zona pellucida and the granulosa cells, that surround the developing follicle and serve as support and/or feeder cells for the follicle, expressed high levels of PPCA transcripts (data not shown). The corpus luteum, which originates from the differentiated granulosa cells after follicle maturation and secretes estrogen and progesterone, displayed even higher levels of mRNA and protein, whereas expression was very low in the interstitial cells (not shown). High expression was also apparent in the columnar epithelial cells and branched tubular glands of the uterus and, during pregnancy, within the rapidly dividing endometrium/trophoblasts. In the affected mouse, foamy macrophages infiltrated the stroma of the ovary and uterus, but the secretory epithelial cells appeared normal (data not shown).
DISCUSSION
It is becoming increasingly clear that the notion of lysosomal genes as simple housekeeping genes (i.e. requiring little or no regulation) may be inaccurate. These enzymes are expressed at basal levels in virtually all cells, but are expressed differentially in specific cell types. For instance, murine prosaposin mRNA is seen in Leydig, Sertoli and peritubular cells but not in the spermatogenic cells of the testis (29, 30) . In contrast, acid phosphatase is detected only in the spermatocytes of this organ (31) . Acid lipase is expressed basally throughout the testis (32), while acid α-glucosidase is seen in the seminiferous tubules but not in the spermatogonia (33) . In this study, we have identified another pattern of expression in the testis, that of PPCA being evident in Leydig and Sertoli cells but not in spermatogenic cells. Similar differential expression for PPCA mRNA and protein exists for virtually all other tissues of the body, being highest in metabolically active or phagocytic cells. This is particularly evident in specific subpopulations of neurons.
The distribution pattern of PPCA and other lysosomal enzymes necessitates some kind of regulation that cannot be anticipated by the housekeeping characteristics of their promoters. Regulation of each of these genes could occur at the transcriptional and/or post-transcriptional levels. It has been reported that human aspartylglucosaminidase is regulated predominantly at the translational level (34) . Moreover, the activity of lysosomal enzymes that rely on other proteins or cofactors/activators for function may be modulated in a more complex fashion. For example, some lysosomal enzymes require other lysosomal proteins for intracellular transport and stability (neuraminidase/ PPCA), activity (sphingolipid degradative enzymes/saposins, β-hexosaminidase/G M2 -activator) or substrate specificity (homo-and heterodimers of β-hexosaminidase) (8, 29, 30, (35) (36) (37) . Despite differences in the expression patterns of many lysosomal proteins, it is noteworthy that their interacting and cooperating proteins are usually co-expressed in specific cells. Little is known about the physiological and pathological stimuli or molecular mechanisms that affect the activity of lysosomal enzymes; however, it is clear that steroid hormones, such as androgens and estrogens, have a general inductive effect on the activity levels of many lysosomal enzymes (38) (39) (40) .
Comparing PPCA levels in normal mouse tissues with the distribution of storage in PPCA knockout mice revealed that, in most cell types, a higher level of expression correlated with more extensive storage. This was particularly evident in the brain where specific neurons, such as the Purkinje and mitral cells, and the cells of the amygdala and entorhinal cortex displayed the most extensive storage. In some neuronal cells such as those of the hippocampus and dentate gyrus, however, this pattern was not maintained. Also, the glomerulus of the kidney expressed virtually no PPCA and yet that of the PPCA(-/-) mouse stored extensively. This apparent discrepancy between endogenous expression levels and the degree of storage in diseased mice could be due to a difference in the spectrum and amounts of substrates, derived during normal cellular processes. Alternatively, PPCA may be expressed in selected cells primarily for its enzymatic function on bioactive peptides, such as oxytocin, substance P or endothelin I (19-21), rather than for its ability to protect neuraminidase and β-galactosidase. In this latter situation, undegraded products would not be expected to accumulate in the knockout model. It is worth noting that the substance P receptor (NK-1 receptor) is well expressed in the hippocampus (41, 42) ; however, it remains to be seen whether the primary requirement for PPCA in these cells is for its role in neuropeptide inactivation.
In PPCA(-/-) mice, we observed differences in the storage within different cell types. Purkinje cells accumulated only a few large PAS-positive storage granules prior to cell death, whereas cerebellar basket cells, and the cells of the amygdala and anterior olfactory nucleus, were almost completely full of fine storage granules before they deteriorated. Epithelial cells of the choroid plexus, renal proximal convoluted tubule and caput epididymis accumulated PAS-negative material and appeared to survive for the entire lifespan of the animal. From these results, it seems clear that some stored intermediates have more toxic effects on cell viability than do others, or that certain cells may be more vulnerable to toxicity. In this regard, both G M2 -ganglioside and one of its downstream degradation products, ceramide, have been implicated in the induction of apoptosis (43) (44) (45) (46) (47) .
The lifespan of cells may also play a role in the correlation between PPCA expression and storage. In the small intestine, we found PPCA mRNA transcripts in the crypts of Lieberkuhn and expression of the protein only in the mucosal epithelium of the microvilli. This is consistent with the newly dividing mucosal cells, differentiating in the crypts to express PPCA transcripts and then translating these transcripts into protein as they move toward the tips of the microvilli. As might be expected, in PPCA(-/-) mice, storage products were never apparent in these cells, probably because their lifespan is too short to allow for accumulation at detectable levels.
The reproductive organs also differentially express PPCA, which is not surprising as lysosomal enzymes have been implicated in reproduction for many years (38, (48) (49) (50) (51) . Both male and female mice express PPCA differentially at specific sites. In the knockout mice, the lack of PPCA considerably disturbs the reproductive capacity of the mice. Although fertile, they mate poorly, and the frequency of pregnancies is less than that for wild-type mice. Litter sizes and delivery, however, appear normal. We do not know at the moment whether this reduced number of pregnancies, which worsens with age, is a result of decreased fertility or whether it is secondary to pathological effects on other organs, including the brain, which may affect performance. It is noteworthy that one of the peptide hormones known to be inactivated by PPCA is oxytocin (19) . The hormone is found in the corpus luteum, which also expresses PPCA at high levels, and stimulates growth during early blastocyst development (52) . Oxytocin and its receptor are also important for parturition and lactation in mammals (53) (54) (55) (56) (57) (58) (59) (60) . It is unclear whether the absence of PPCA in the knockout mouse model hampers processing or clearance of oxytocin in the uterus, which could have detrimental effects on the continuing pregnancy. Curiously, it has been reported that mothers of human GS patients, who have 50% PPCA activity, often suffer from spontaneous abortions (61) .
This detailed study highlights some important factors regarding the expression of lysosomal enzymes and the consequences of their functional loss. It is clear that there are marked differences in the expression levels of lysosomal enzymes in different cell types. Questions remain as to the specific cellular distribution of enzyme substrates and the differential toxicity of accumulated substrates in different cell types throughout the body. A detailed map of expression and storage will be extremely valuable in the accurate assessment of correction following therapeutic regimes.
MATERIALS AND METHODS

Materials
Chemicals were obtained from standard commercial suppliers. [α- 35 S]UTP (>1000 Ci/mmol; Amersham), was used to prepare riboprobes for in vitro transcription assays, which included either T7 or T3 RNA polymerase (Promega Biotec).
In situ RNA hybridization FVB mice (8-12 weeks old) were anesthesized sublethally with avertin and subsequently perfused with freshly prepared 4% paraformaldehyde in 0.1 M sodium phosphate buffer, pH 7.4. Tissues were isolated and post-fixed for 2-4 h, before being processed for cryostat sectioning. Sections (10-14 µm) were placed on Superfrost/Plus (Fisher Scientific) glass slides and hybridized for 16-20 h at 50°C with a 272 bp murine PPCA 35 S-labeled riboprobe (position 904-1176 bp of the mouse PPCA cDNA), as previously described (23, 62) . This probe detects both the predominant ubiquitous 1.8 kb and the minor 2.0 kb PPCA mRNA. The washed slides were dipped in photographic emulsion (Kodak NTB-2) and developed after 5-8 days with Kodak D-19 developer and fixer. The slides were then counterstained with 0.1% toluidine blue and mounted.
Immunocytochemical and histological staining
Mice were perfused via the left cardiac ventricle at a rate of 3.5 ml/min for 2 min with phosophate-buffered saline (PBS) to remove circulating blood cells. They were perfused further for 15 min with 4% paraformaldehyde in 0.1 M sodium phosphate, pH 7.4. Tissues were removed and fixed for a further 4 h in the same fixative before being paraffin embedded. Tissue sections (10 µm for brain; 4 µm for all other tissues) were deparaffinized and rehydrated and the antigen was retrieved by microwave boiling in 0.1 M citrate, pH 6.0, and cooling for 30 min. The sections were then blocked in PBS (containing 0.05% Tween-20 and 0.1% bovine serum albumin) and 10% normal goat serum for 30 min before being incubated overnight at room temperature with anti-mouse PPCA antibodies. The latter were raised in rabbit against the native mouse PPCA precursor, overproduced in insect cells infected with a PPCA recombinant baculovirus construct. The polyclonal antibody preparation was shown previously to be monospecific for the mouse 54 kDa precursor and mature subunits (63) . The Vector ABC-HRP system was used for detection. After a secondary antibody incubation of 2 h, endogenous peroxidase activity was removed by adding PBS containing 0.3% hydrogen peroxide and 0.02% sodium azide for 30 min. The ABC-HRP complex was then added for 1 h and visualized by adding a VIP substrate (Vector) for 3-8 min. Nuclei were counterstained with methyl green. For histological staining with hematoxylin/eosin, tissues were paraffin embedded (see above), and, for PAS staining, tissues were processed for frozen sectioning (17) .
